Literature DB >> 34671573

Hypothyroid Crisis: Oral or Intravenous Treatment? A Report of Two Cases.

Rens Jr Gadaen1, Roderick F Tummers-de Lind van Wijngaarden1.   

Abstract

BACKGROUND: Hypothyroid crisis, or myxoedema coma, is a rare condition with high mortality and must be treated promptly. Even though it may be unfavourable, most guidelines only focus on intravenous drug administration due to lack of data on oral treatment. METHODS/
RESULTS: The course of oral treatment in two patients admitted in our hospital is described. Patients were treated with levothyroxine 1.3 μg/kg and liothyronine 25 μg twice daily, followed after 1 week with only levothyroxine 1.3 μg/kg daily. Oral treatment was successful in both patients without complications or side-effects.
CONCLUSIONS: Oral substitution is an appropriate alternative to intravenous substitution, which has potential disadvantages and is associated with higher mortality. LEARNING POINTS: Hypothyroid crisis or myxoedema coma is a rare condition with a high mortality rate, so early diagnosis and prompt treatment are necessary.High-dose intravenous treatment is associated with higher mortality, so oral substitution may be an acceptable approach, especially as intravenous medicines are not widely available. © EFIM 2021.

Entities:  

Keywords:  Hypothyroid crisis; myxoedema coma; oral treatment

Year:  2021        PMID: 34671573      PMCID: PMC8523370          DOI: 10.12890/2021_002752

Source DB:  PubMed          Journal:  Eur J Case Rep Intern Med        ISSN: 2284-2594


  7 in total

1.  Myxoedema coma: response of thyroid hormones with oral and intravenous high-dose L-thyroxine treatment.

Authors:  S Arlot; X Debussche; J D Lalau; A Mesmacque; M Tolani; J Quichaud; A Fournier
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

2.  A diagnostic scoring system for myxedema coma.

Authors:  Geanina Popoveniuc; Tanu Chandra; Anchal Sud; Meeta Sharma; Marc R Blackman; Kenneth D Burman; Mihriye Mete; Sameer Desale; Leonard Wartofsky
Journal:  Endocr Pract       Date:  2014-08       Impact factor: 3.443

Review 3.  Myxedema coma: diagnosis and treatment.

Authors:  C R Wall
Journal:  Am Fam Physician       Date:  2000-12-01       Impact factor: 3.292

4.  Oral Levothyroxine is an Effective Option for Myxedema Coma: A Single-Centre Experience.

Authors:  Arjun Rajendran; Nisha Bhavani; Vasantha Nair; Praveen V Pavithran; V Usha Menon; Harish Kumar
Journal:  Eur Thyroid J       Date:  2020-06-11

5.  Treatment of myxoedema coma--factors associated with fatal outcome.

Authors:  B Hylander; U Rosenqvist
Journal:  Acta Endocrinol (Copenh)       Date:  1985-01

Review 6.  Clinical concepts on thyroid emergencies.

Authors:  Giampaolo Papi; Salvatore Maria Corsello; Alfredo Pontecorvi
Journal:  Front Endocrinol (Lausanne)       Date:  2014-07-01       Impact factor: 5.555

7.  Split high-dose oral levothyroxine treatment as a successful therapy option in myxedema coma.

Authors:  Suranut Charoensri; Chutintorn Sriphrapradang; Hataikarn Nimitphong
Journal:  Clin Case Rep       Date:  2017-09-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.